CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 12,750
+740 (6.16%)
At close: Sep 4, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 164.54 billion as of September 4, 2026. Its market cap has decreased by -52.46% in one year.
Market Cap
164.54B
Enterprise Value
127.23B
Revenue
2.15B
Ranking
n/a
PE Ratio
21.23
Stock Price
12,750.00
ChartMarket Cap Chart
Since October 16, 2024, CellBion's market cap has decreased from 263.06B to 164.54B, a decrease of -37.45%. That is a compound annual growth rate of -22.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 164.54B | -45.66% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DAE HWA Pharmaceutical | 201.91B |
| GC WellBeing | 193.03B |
| NOVAREX | 183.20B |
| Vivozon Pharmaceutical | 177.49B |
| Cosmax Nbt | 169.58B |
| Kyung Dong Pharmaceutical | 149.43B |
| PHARMARESEARCH BIO | 127.72B |
| Ahn-Gook Pharmaceutical | 119.22B |